Alzheimer's drug shows promise in early results of study

Shares of Biogen and other drugmakers researching Alzheimer's disease soared early Wednesday after Japan's Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study.

from The Washington Times stories: Health https://ift.tt/ac0ZGg5